Feed Top Reports Pricing

⌘K

16:41:05·8h

SECFiling

SEC Form DEF 14A filed by Nkarta Inc.

NKTX· Nkarta Inc.

Health Care

Original source

Companies

NKTX
Nkarta Inc.
Health Care

Recent analyst ratings

May 15UpdateWilliam Blair-
Oct 9UpdateRodman & Renshaw$14.00
Aug 14UpdateRaymond James$16.00
Mar 22UpdateRaymond James$16.00
Dec 22UpdateOppenheimer-
Oct 10UpdateCanaccord Genuity$25.00

Related

SEC8h
SEC Form DEFA14A filed by Nkarta Inc.
PR8d
Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers
PR14d
Nkarta to Participate in Needham Virtual Healthcare Conference
SEC18d
SEC Form EFFECT filed by Nkarta Inc.
SEC20d
SEC Form 424B5 filed by Nkarta Inc.
SEC29d
SEC Form S-3 filed by Nkarta Inc.
SEC29d
SEC Form 10-K filed by Nkarta Inc.
SEC29d
Nkarta Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022

SEC Form DEF 14A filed by Nkarta Inc. | Quantisnow